Top Health-care stocks:
Health-care shares were flat in pre-market trade Wednesday.
In health-care stocks news, RedHill Biopharma's ( RDHL ) American depositary shares were up 2.1% after the Israeli biopharmaceutical company said it is expanding an ongoing late-stage study of RHB-105 as the Food and Drug Administration has authorized RedHill to pursue a new, distinct and broader indication for RHB-105 as a first-line treatment of Helicobacter pylori infection.
And, Acura Pharmaceuticals ( ACUR ) said it received a $300,000 grant by the National Institute On Drug Abuse of the National Institutes of Health to fund Phase I development of the company's new, early stage Limitx abuse deterrent technology.
The Grant is based on a proposal submitted by the company to advance the development of a self-regulating hydromorphone tablet intended to deter abuse by excess oral consumption of the tablets.
Under the terms of the Grant, the company must complete Phase I development by February 28, 2015.
Finally, Transcription Billing ( MTBC ), the health care information technology company that completed its initial public offering on July 28, reported a narrower-than-expected adjusted loss in Q2.
Non-GAAP adjusted loss of $0.01 per diluted share in the April-to-June period, narrower than the $0.05 loss estimated by one analyst polled by Capital IQ.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.